Log in to save to my catalogue

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclini...

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclini...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2687689721

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

About this item

Full title

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

Publisher

United States: Public Library of Science (PLoS)

Journal title

PLOS ONE, 2022-05, Vol.17 (5), p.e0269265

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science (PLoS)

More information

Scope and Contents

Contents

This cross-sectional study aims to investigate the association between subclinical atherosclerosis and metabolic dysfunction-associated fatty liver disease (MAFLD) or non-alcoholic fatty liver disease (NAFLD), and a synergistic effect of diabetes mellitus (DM) and MAFLD on subclinical atherosclerosis.
Of 977 subjects who underwent health checkup...

Alternative Titles

Full title

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2687689721

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2687689721

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0269265

How to access this item